Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1886086 | 0.91 | CYP3A4 (0.46) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14717498 | 0.91 | CYP3A4 (0.46) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14717657 | 0.91 | CYP3A4 (0.32) | CYP3A4 | |
| SCHEMBL14717357 | 0.91 | CYP3A4 (0.52) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14716825 | 0.90 | CYP3A4 (0.44) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14717322 | 0.89 | CYP3A4 (0.53) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14717558 | 0.89 | CYP3A4 (0.43) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14717487 | 0.89 | CYP3A4 (0.43) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14718083 | 0.89 | CYP3A4 (0.43) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL14718119 | 0.89 | CYP3A4 (0.43) | CYP3A4TSHRLPAR3LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023279279-A1 | METHOD FOR TREATING TAIL GAS | 安徽金禾实业股份有限公司 | 2023-01-12 | — | — | WO | claimed |
| CN-113646062-B | Tail gas treatment method | 安徽金禾实业股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-107710462-B | Electrochemical hydrogen storage electrode and battery | 巴斯夫公司 | 2022-08-02 | — | — | CN | claimed |
| CN-108949141-B | Preparation method of bistable electrochromic material and application of bistable electrochromic material in preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-111117594-A | Electrochromic material based on dynamic metal-ligand complexation and electrochromic device | 吉林大学 | 2020-05-08 | — | — | CN | claimed |
| EP-2577003-B1 | METHOD AND APPARATUS FOR OPERATING A STEAM CYCLE PROCESS WITH A LUBRICATED EXPANDER | MAN TRUCK & BUS AG (DE) | 2018-07-18 | — | — | EP | claimed |
| US-20160365228-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION | 2016-12-15 | — | — | US | claimed |
| US-9449797-B2 | Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface | LAM RESEARCH CORPORATION (US) | 2016-09-20 | — | — | US | claimed |
| US-9382816-B2 | Method and apparatus for operating a steam cycle process with a lubricated expander | MAN TRUCK & BUS AG (DE) | 2016-07-05 | — | — | US | claimed |
| US-20140335698-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION (US) | 2014-11-13 | — | — | US | claimed |
| US-20130263598-A1 | Method and Apparatus for Operating a Steam Cycle Process with a Lubricated Expander | MAN TRUCK & BUS AG (DE) | 2013-10-10 | — | — | US | claimed |
| US-20240285766-A1 | Liquid Protein Formulations Containing Ionic Liquids | EAGLE BIOLOGICS, INC. | 2024-08-29 | — | — | US | disclosed |
| US-11986526-B2 | Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC) | EAGLE BIOLOGICS, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| CN-111117594-B | Electrochromic material and electrochromic device based on dynamic metal-ligand complexation | 吉林大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-110559435-B | Liquid protein formulations comprising ionic liquids | 伊戈尔生物药品股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-104078686-A | CURRENT COLLECTOR FOR SECONDARY BATTERY AND SECONDARY BATTERY COMPRISING THE SAME | SK INNOVATION CO LTD | 2014-10-01 | — | — | CN | disclosed |
| US-20140005415-A1 | IMMOBILIZATION OF IONIC LIQUIDS VIA MECHNOCHEMICAL INTERCALATION IN LAYERED MATERIALS | TEXAS STATE UNIVERSITY-SAN MARCOS (US) | 2014-01-02 | — | — | US | disclosed |
| US-20130263598-A1 | Method and Apparatus for Operating a Steam Cycle Process with a Lubricated Expander | MAN TRUCK & BUS AG (DE) | 2013-10-10 | — | — | US | disclosed |
| US-20130053287-A1 | SYNTHETIC LUBRICANT | THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-02-28 | — | — | US | disclosed |
| WO-2011091131-A2 | ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240285766-A1 | Liquid Protein Formulations Containing Ionic Liquids | IGFBP5, IGFBP1, IGF2BP1 | CYP3A4 4546/4885TSHR 2121/4885LPAR3 2747/4885 |
| US-20140005415-A1 | IMMOBILIZATION OF IONIC LIQUIDS VIA MECHNOCHEMICAL INTERCALATION IN LAYERED MATERIALS | CALCOCO2, MCOLN2, MECP2 | CYP3A4 983/4885TSHR 2608/4885LPAR3 3588/4885 |
| US-11986526-B2 | Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC) | MLEC, DMPK, CD14 | CYP3A4 1133/4885TSHR 2660/4885LPAR3 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.